Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 3
1991 3
1993 2
1994 1
1996 4
1997 2
1998 2
2000 2
2001 1
2002 1
2003 4
2004 6
2005 6
2006 2
2007 5
2008 7
2009 9
2010 16
2011 31
2012 40
2013 60
2014 51
2015 52
2016 38
2017 34
2018 30
2019 28
2020 17
2021 10
2022 2
2023 3
2024 3

Search Results

400 results

Results by year

Filters applied: . Clear all
Page 1
Designer drugs: a medicinal chemistry perspective (II).
Carroll FI, Lewin AH, Mascarella SW, Seltzman HH, Reddy PA. Carroll FI, et al. Ann N Y Acad Sci. 2021 Apr;1489(1):48-77. doi: 10.1111/nyas.14349. Epub 2020 May 12. Ann N Y Acad Sci. 2021. PMID: 32396701 Review.
Designer drugs: a medicinal chemistry perspective.
Carroll FI, Lewin AH, Mascarella SW, Seltzman HH, Reddy PA. Carroll FI, et al. Ann N Y Acad Sci. 2012 Feb;1248:18-38. doi: 10.1111/j.1749-6632.2011.06199.x. Epub 2011 Nov 17. Ann N Y Acad Sci. 2012. PMID: 22092008 Review.
Designer drugs - A continuing chemical (R)evolution.
Taffe MA, Olive MF. Taffe MA, et al. Neuropharmacology. 2018 May 15;134(Pt A):1-3. doi: 10.1016/j.neuropharm.2018.03.037. Epub 2018 Mar 29. Neuropharmacology. 2018. PMID: 29605651 No abstract available.
Metabolism of designer drugs of abuse.
Staack RF, Maurer HH. Staack RF, et al. Curr Drug Metab. 2005 Jun;6(3):259-74. doi: 10.2174/1389200054021825. Curr Drug Metab. 2005. PMID: 15975043 Review.
The Evolving Landscape of Designer Drugs.
Kacinko SL, Papsun DM. Kacinko SL, et al. Methods Mol Biol. 2019;1872:129-135. doi: 10.1007/978-1-4939-8823-5_13. Methods Mol Biol. 2019. PMID: 30350286
Pharmacological profile of methylphenidate-based designer drugs.
Luethi D, Kaeser PJ, Brandt SD, Krähenbühl S, Hoener MC, Liechti ME. Luethi D, et al. Neuropharmacology. 2018 May 15;134(Pt A):133-140. doi: 10.1016/j.neuropharm.2017.08.020. Epub 2017 Aug 18. Neuropharmacology. 2018. PMID: 28823611 Free article.
The evolving high: new designer drugs of abuse.
Pourmand A, Armstrong P, Mazer-Amirshahi M, Shokoohi H. Pourmand A, et al. Hum Exp Toxicol. 2014 Oct;33(10):993-9. doi: 10.1177/0960327113514100. Epub 2014 Feb 5. Hum Exp Toxicol. 2014. PMID: 24501103 Review.
400 results